Regeneron Pharmaceuticals

REGN(Regeneron Pharmaceuticals)

$624.14+0.3%

REGN(Regeneron Pharmaceuticals) Price Prediction Summary

AI-Generated
As of July 1, 2026, REGN is caught between conflicting technical signals and a structurally supportive environment. Technical indicators show divergence—the 20-day moving average favors bulls while the 50-day and 200-day anchor resistance, with MACD slightly bullish but RSI neutral. Sentiment and structure paint a more constructive backdrop: option traders favor upside \(put/call 0.36\), volatility expectations remain low \(IV rank 28\), and institutional ownership at 92.26\% combined with minimal short interest \(3.33\%\) suggest structural support for accumulation. The key uncertainty is whether technicals break bullish \(price above the 50-day\) or continue grinding below major moving averages; the analyst consensus target of 833 implies meaningful upside if breakout occurs. Watch the 50-day moving average as the critical fulcrum—a close above 659.53 would validate sentiment and structure, while sustained weakness below 618 would risk deeper consolidation.
Technical Indicators
Mixed / Divergence Signals

SMA20 signals buy but major moving averages remain bearish; MACD marginally bullish while RSI sits neutral.

Market Sentiment
Slightly Bullish Bias

Low IV rank and favorable put/call ratio suggest mild bullish lean; consensus target price implies upside room.

Market Structure
Bullish Chip Distribution

Institutional ownership dominates at 92.26%; short float remains minimal at 3.33% of shares.

Key Trading Levels

How Gate Predicts REGN(Regeneron Pharmaceuticals) Price

Multi-Source Data Collection

Three independent data sources—technical indicators, market sentiment, and market structure signals—are integrated in real time, covering price behavior, trader behavior, and supply-demand dynamics, ensuring the analysis does not rely on a single dimension.

Independent Analysis by Dimension

Technical indicators are used to identify trends and structural positions, market sentiment is used to assess risk appetite, and market structure signals are used to identify supply-demand and positioning changes. Each dimension independently generates signals within its most appropriate time frame.

Cross-Validation of Composite Signals

When signals across multiple dimensions align, confidence in the assessment increases; when signals diverge, it indicates a transitional or consolidation phase, helping to avoid being misled by a single indicator.

Technical Indicators

AI-GeneratedAs of July 1, 2026, **REGN technical analysis** shows internal contradiction between shorter and longer-term signals. The 20-day simple moving average at 618.83 generates a buy signal, yet the 50-day at 659.53 and 200-day at 699.52 both flash sell signals—suggesting price remains trapped below both intermediate and longer-term trend anchors. The MACD at −7.26 reads negative overall but produces a buy signal from its recent crossover structure, hinting at potential momentum shift; however, this remains tentative. The RSI at 49.65 sits squarely neutral, offering no conviction in either direction. The near-term REGN price forecast hinges on whether buyers can hold the 20-day and push above 659, or if sellers defend the 50-day floor. Price structure clearly favors bears until a decisive break above the 50-day occurs.
IndicatorValueSignal
Exponential Moving Average (10)622.7023
Buy
Exponential Moving Average (100)681.8636
Sell
Exponential Moving Average (20)625.1744
Sell
Exponential Moving Average (200)690.4728
Sell
Exponential Moving Average (30)634.0552
Sell
Exponential Moving Average (50)654.137
Sell
Hull Moving Average (9)630.4824
Sell
Ichimoku Base Line (9, 26, 52, 26)620.0075
neutral
Moving Averages Summary
neutral
Simple Moving Average (10)620.494
Buy
Simple Moving Average (100)712.2193
Sell
Simple Moving Average (20)618.5285
Buy
Simple Moving Average (200)699.4898
Sell
Simple Moving Average (30)621.1447
Buy
Simple Moving Average (50)659.406
Sell
Volume Weighted Moving Average (20)617.6449
Buy
Average Directional Index (14)30.0499
neutral
Awesome Oscillator-0.6758
neutral
Bull Bear Power11.977
Sell
Commodity Channel Index (20)67.9536
neutral
MACD Level (12, 26)-7.7517
Buy
Momentum (10)9.99
Buy
Oscillators Summary
neutral
Relative Strength Index (14)46.4845
neutral
Stochastic %K (14, 3, 3)72.4806
neutral
Stochastic RSI Fast (3, 3, 14, 14)80.6052
neutral
Ultimate Oscillator (7, 14, 28)43.3892
neutral
Williams Percent Range (14)-32.0109
neutral
Technical Summary
neutral

Market Sentiment

AI-GeneratedAs of July 1, 2026, **REGN market sentiment** tilts modestly bullish despite subdued volatility expectations. The implied volatility rank at 28 reflects low option-market fear—traders are not pricing elevated risk, which often precedes rallies when sentiment is this calm. The put/call ratio of 0.3590 sits well below 1.0, indicating calls substantially outnumber puts; this skew favors upside and suggests positioning leans optimistic. The consensus target mean price of 833.31 sits notably above current levels, embedding meaningful upside expectation from the analyst and options community. Together, these REGN price prediction indicators paint a patient, moderately constructive picture—no panic, no extreme complacency, but a structural bias toward accumulation. Watch whether IV rank climbs above 35; sustained elevation would suggest confidence erosion among option traders.
Analyst Rating
833.3061
Options Put/Call Ratio
226.5300%
Implied Volatility (IV)
27.7871

Market Structure

AI-GeneratedAs of July 1, 2026, **REGN market structure** reflects strong institutional ownership with minimal short pressure. Institutions control 92.26\% of float, an overwhelming majority that typically anchors stability and reduces downside tail risk—large asset managers rarely trigger sharp sell-offs. The short percent of float sits at only 3.33\%, well below economy-wide averages and indicating very low near-term forced-cover risk. This structural setup creates a favorable environment for accumulation; with few shorts to squeeze and deep institutional pockets standing guard, the stock lacks a typical near-term catalyst for panic liquidation. The REGN market analysis lens suggests that any pullback likely attracts institutional buyers rather than triggering cascading exits. Institutional dominance also means price moves tend to be gradual and deliberate rather than whippy. Monitor whether institutional holding ratio shrinks below 90\% or short float creeps above 5\%—either shift would signal changing structure.
Float Shares
97669471.0000
Short % of Float
0.0333
Institutional Holding
0.9223

Influencing Factors

Corporate Earnings and Profit Growth

Revenue, net profit, and forward guidance are the core factors affecting stock prices.

Industry Competition Landscape and Market Share

Changes in a company's competitiveness within the industry and its market share will impact its long-term valuation.

Overall Market Valuation and Interest Rate Environment

When interest rates rise or overall market valuations are elevated, individual stocks are more likely to experience pullbacks.

Institutional Funds and Market Sentiment

Large-scale institutional inflows or outflows, along with changes in market risk appetite, can amplify stock price volatility.

FAQ

What data is used to generate the REGN(Regeneron Pharmaceuticals) price prediction?

x

REGN(Regeneron Pharmaceuticals) price prediction is typically based on three types of data: technical indicators (e.g., RSI, MACD, moving averages), market sentiment (e.g., capital flows and derivatives data), and market structure signals (e.g., positioning and supply-demand changes). Multi-dimensional data is used to enhance the completeness of the analysis.

How do supply and demand affect the REGN(Regeneron Pharmaceuticals) price prediction?

x

How are technical indicators used in the REGN(Regeneron Pharmaceuticals) price prediction?

x

What role does market sentiment play in the REGN(Regeneron Pharmaceuticals) price prediction?

x

What common factors can influence the REGN(Regeneron Pharmaceuticals) price prediction?

x

How can price predictions be used to assess the current market state of REGN(Regeneron Pharmaceuticals)?

x

Disclaimer

Gate only provides trade execution services. Any information, reports, opinions, comments, or other materials obtained from Gate, its employees, Gate-provided analytical tools, or third-party research do not constitute investment advice and should not be relied upon for investment decisions. You agree to do your own research and verify external information sources before making any investment. You further agree that Gate shall not be held liable for any loss or damage (including but not limited to loss of profits) arising directly or indirectly from the use of or reliance on such information. Nothing contained in any reports shall be interpreted as an explicit or implied promise, guarantee, or indication of profit, nor does it guarantee that losses can be limited or avoided. Please also note that data related to traditional finance such as forex and CFDs (e.g., real-time prices) displayed on this page is sourced from third parties, is provided for reference only, and is offered on an "as-is" basis without any representations or warranties of any kind, express or implied. Any third-party website links provided are not under Gate's control. Gate assumes no responsibility for the reliability or accuracy of such third-party websites or their content. For further details, please refer to our User Agreement.

Risk Warning

Traditional finance such as forex and CFDs may experience significant price fluctuations. Past performance is not a reliable indicator of future results. The vast majority of retail client accounts incur losses when trading forex and CFDs. Please ensure you fully understand how forex and CFDs operate and assess whether you are able to bear the risk of substantial losses. Even with stop-loss orders, your losses may exceed your initial deposit. Therefore, you should not engage in speculative trading with funds you cannot afford to lose, and you should ensure you are fully aware of the risks involved. The information provided by Gate is general in nature and does not take into account your investment objectives, financial situation, or specific needs. The content and prices on this website must not be interpreted as personal investment advice. Please ensure you fully understand the risks involved and seek independent professional advice where necessary. Gate reserves the right to terminate services at its sole discretion at any time. Gate is not liable for any losses resulting from such termination, including losses caused by closing positions at unfavorable market prices or forced liquidation. For more information, please refer to our Risk Disclosure.